Loading...
Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy
Synovial sarcoma (SS) is considered to be a chemosensitive, soft tissue sarcoma. Therefore, neoadjuvant and/or adjuvant chemotherapy (N/AC) is used for the treatment of high-risk SS patients. However, the role of N/AC remains controversial. The present study aimed to review the clinical outcomes of...
Na minha lista:
| Udgivet i: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587004/ https://ncbi.nlm.nih.gov/pubmed/31281649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1863 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|